Assignee
I MAB BIOPHARMA HANGZHOU CO LTD
CN·1 granted patent·3 pending applications·1 citations·filing 2020–2025
Top patents by PatentIndex Score
4 records- 0181US11926662B2Anti-GM-CSF antibodies and uses thereofI MAB BIOPHARMA HANGZHOU CO LTD·Filed 2020·Granted Mar 12, 2024·1 cites·8 claims
- 0253US2025332218A1Formulation containing soluble gp130 dimer and method for using sameI MAB BIOPHARMA HANGZHOU CO LTD·Filed 2021·Application pending·0 cites
- 0351US2021347903A1Anti-ifnar1 antibodies for treating autoimmune diseasesI MAB BIOPHARMA HANGZHOU CO LTD·Filed 2021·Application pending·0 cites
- 0434US2025288517A1Liquid pharmaceutical formulation of anti-gm-csf antibody and uses thereofI MAB BIOPHARMA HANGZHOU CO LTD·Filed 2025·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when I MAB BIOPHARMA HANGZHOU CO LTD files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →